Lipidated PSA compositions and methods
US-10857177-B2 · Dec 8, 2020 · US
Lipopolysaccharides
Lipopolysaccharides · Cooperative Patent Classification (CPC)
Agriculture, food, personal care, health, and life sciences.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | A61K31/739 |
| Official title | Lipopolysaccharides |
| Display label | Lipopolysaccharides |
| Total patents | 116 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 8 |
| 2016 | 10 |
| 2017 | 10 |
| 2018 | 11 |
| 2019 | 14 |
| 2020 | 12 |
| 2021 | 14 |
| 2022 | 12 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 13 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Extended release immunomodulatory implant to facilitate bone morphogenesis
US-2020316262-A1 · Oct 8, 2020 · US
Extended release immunomodulatory implant to facilitate bone morphogenesis
US-2020315800-A1 · Oct 8, 2020 · US
Use of imidazopyrimidine for modulating human immune response
US-2020282048-A1 · Sep 10, 2020 · US
Sphingamide compounds and methods for binding iNKT cells
US-10723750-B2 · Jul 28, 2020 · US
Brain function-improving agent, food, and medicine using lipopolysaccharide
US-2020179436-A1 · Jun 11, 2020 · US
Compositions comprising bacterial strains
US-10610550-B2 · Apr 7, 2020 · US
Immunotherapeutic potential of modified lipooligosaccharides/lipid a
US-2019367959-A1 · Dec 5, 2019 · US
Anti-cancer agent comprising HVJ-E and CXCL2
US-10441613-B2 · Oct 15, 2019 · US
Composition for inhibiting survival or growth of tubercle bacillus by adjusting polarization of macrophage, and method using same
US-2019307850-A1 · Oct 10, 2019 · US
Glycolipid compositions and methods of use
US-2019290680-A1 · Sep 26, 2019 · US
SPHINGAMIDE COMPOUNDS AND METHODS FOR BINDING iNKT CELLS
US-2019256541-A1 · Aug 22, 2019 · US
Compositions comprising bacterial strains
US-10357520-B2 · Jul 23, 2019 · US
Immunotherapeutic potential of modified lipooligosaccharides/lipid A
US-10358667-B2 · Jul 23, 2019 · US
Therapy-enhancing glucan
US-10307479-B2 · Jun 4, 2019 · US
Compositions comprising bacterial strains
US-2019134109-A1 · May 9, 2019 · US
Methods for treating cancer and inhibiting graft rejection
US-2019134089-A1 · May 9, 2019 · US
HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS WITH ALTERED GLYCOSYL GROUPS
US-2019099486-A1 · Apr 4, 2019 · US
Immunostimulatory combinations
US-2019083592-A1 · Mar 21, 2019 · US
Method of attenuating reactions to skin irritants
US-10226476-B2 · Mar 12, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC A61K31/739?
- CPC A61K31/739 is the Cooperative Patent Classification code for “Lipopolysaccharides.”
- How many patents are filed under CPC A61K31/739 (Lipopolysaccharides)?
- Our database includes 116 publications tagged with this CPC code.
- Is patent activity under CPC A61K31/739 growing?
- Publication counts under this code: 3 in 2024 vs 13 in 2025 (latest complete years).